Sutro Biopharma, Inc. (STRO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 14.52M | 11.65M | 9.69M | 63.74M | 17.4M | 14.81M | 8.52M | 25.71M | 13.01M | 113.72M | 16.92M | 10.41M |
| Revenue Growth % | -16.53% | -21.35% | 13.77% | 147.98% | 33.76% | -86.98% | -49.66% | 146.89% | 2.64% | 1217.44% | -32.7% | -62.94% |
| Cost of Goods Sold | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 | 1.79M | 1.76M | 0 | 0 | 41.59M |
| COGS % of Revenue | 8.8% | - | - | - | - | - | - | 6.96% | 13.54% | - | - | 399.46% |
| Gross Profit | 13.24M | 11.65M | 9.69M | 63.74M | 17.4M | 14.81M | 8.52M | 23.92M | 11.25M | 113.72M | 16.92M | -31.18M |
| Gross Margin % | 91.2% | 100% | 100% | 100% | 100% | 100% | 100% | 93.04% | 86.46% | 100% | 100% | -299.46% |
| Gross Profit Growth % | -23.87% | -21.35% | 13.77% | 166.54% | 54.7% | -86.98% | -49.66% | 176.7% | -11.26% | 429.6% | -32.7% | -210.98% |
| Operating Expenses | 42.86M | 45.3M | 58.15M | 67.09M | 85.91M | 80.07M | 76.44M | 72.6M | 67.84M | 70.57M | 60.94M | 15M |
| OpEx % of Revenue | 295.11% | 388.98% | 599.94% | 105.25% | 493.78% | 540.66% | 897.17% | 282.43% | 521.51% | 62.05% | 360.07% | 144.05% |
| Selling, General & Admin | 7.58M | 8.66M | 8.74M | 10.34M | 13.27M | 9.03M | 14.33M | 12.37M | 10.96M | 16.8M | 15.27M | 15M |
| SG&A % of Revenue | 52.22% | 74.37% | 90.18% | 16.23% | 76.29% | 60.98% | 168.2% | 48.13% | 84.26% | 14.78% | 90.22% | 144.05% |
| Research & Development | 36.55M | 36.64M | 39.85M | 38.33M | 51.6M | 71.04M | 62.11M | 62.02M | 56.88M | 53.77M | 45.67M | 41.59M |
| R&D % of Revenue | 251.69% | 314.6% | 411.15% | 60.12% | 296.55% | 479.69% | 728.97% | 241.27% | 437.25% | 47.28% | 269.85% | 399.46% |
| Other Operating Expenses | -1000K | 0 | 1000K | 1000K | 1000K | 0 | 0 | -1000K | 0 | 0 | 0 | -1000K |
| Operating Income | -29.61M | -33.66M | -48.46M | -3.35M | -68.51M | -65.26M | -67.92M | -48.69M | -56.59M | 43.15M | -44.01M | -46.18M |
| Operating Margin % | -203.91% | -288.98% | -499.94% | -5.25% | -393.78% | -440.66% | -797.17% | -189.39% | -435.05% | 37.95% | -260.07% | -443.52% |
| Operating Income Growth % | 56.78% | 48.42% | 28.65% | 93.13% | -21.07% | -251.23% | -54.31% | -5.43% | -33.98% | 187.67% | -107.52% | -138.29% |
| EBITDA | -28.34M | -32.03M | -46.56M | -1.45M | -66.61M | -63.39M | -66.12M | -46.9M | -54.83M | 44.88M | -42.27M | -44.45M |
| EBITDA Margin % | -195.11% | -275.03% | -480.34% | -2.27% | -382.86% | -428.05% | -776.06% | -182.43% | -421.51% | 39.47% | -249.79% | -426.89% |
| EBITDA Growth % | 57.46% | 49.47% | 29.58% | 96.92% | -21.49% | -241.23% | -56.4% | -5.51% | -34.98% | 194.11% | -113.81% | -147.18% |
| D&A (Non-Cash Add-back) | 1.28M | 1.62M | 1.9M | 1.9M | 1.9M | 1.87M | 1.8M | 1.79M | 1.76M | 1.73M | 1.74M | 1.73M |
| EBIT | -29.61M | -36.52M | -46.45M | -826K | -47.47M | -61.4M | -40.88M | -40.72M | -51.03M | 55.6M | -38.77M | -46.18M |
| Net Interest Income | -7.83M | -8.79M | -8.4M | -7.13M | -7.45M | -4.83M | 19.13M | -4.13M | -5.3M | -4.17M | -4.13M | -515K |
| Interest Income | 1.64M | 1.53M | 2.01M | 2.52M | 3.19M | 3.86M | 27.04M | 4.91M | 4.1M | 4.56M | 4.55M | 2.84M |
| Interest Expense | 9.47M | 10.33M | 10.41M | 9.65M | 10.64M | 8.69M | 7.91M | 9.04M | 9.4M | 8.73M | 8.68M | 3.36M |
| Other Income/Expense | -8.88M | -13.19M | -8.4M | -8.17M | -7.45M | -4.83M | 19.13M | 675K | -1.62M | 3.72M | -3.43M | 7.81M |
| Pretax Income | -38.5M | -46.84M | -56.86M | -11.52M | -75.97M | -70.09M | -48.79M | -48.01M | -58.21M | 46.87M | -47.45M | -38.37M |
| Pretax Margin % | -265.09% | -402.2% | -586.58% | -18.07% | -436.62% | -473.28% | -572.62% | -186.77% | -447.52% | 41.22% | -280.34% | -368.55% |
| Income Tax | -15K | -82K | 0 | -18K | 0 | 2.35M | 0 | 8K | 0 | 15.81M | 1.84M | 151K |
| Effective Tax Rate % | 0.04% | 0.18% | 0% | 0.16% | 0% | -3.36% | 0% | -0.02% | 0% | 33.72% | -3.88% | -0.39% |
| Net Income | -38.48M | -46.76M | -56.86M | -11.5M | -75.97M | -72.44M | -48.79M | -48.02M | -58.21M | 31.07M | -49.28M | -38.52M |
| Net Margin % | -264.99% | -401.49% | -586.58% | -18.04% | -436.62% | -489.18% | -572.62% | -186.8% | -447.52% | 27.32% | -291.21% | -370% |
| Net Income Growth % | 49.34% | 35.45% | -16.54% | 76.05% | -30.5% | -333.2% | 1.01% | -24.64% | -16.31% | 189.8% | -152.89% | -48.1% |
| Net Income (Continuing) | -38.48M | -46.76M | -56.86M | -11.5M | -75.97M | -72.44M | -48.79M | -48.02M | -58.21M | 31.07M | -49.28M | -38.52M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.94 | -5.45 | -6.70 | -1.40 | -9.10 | -8.80 | -5.90 | -5.90 | -9.50 | 5.10 | -8.10 | -6.40 |
| EPS Growth % | 67.69% | 38.07% | -13.56% | 76.27% | 4.21% | -272.55% | 27.16% | 7.81% | -11.76% | 178.46% | -138.24% | -16.36% |
| EPS (Basic) | -2.94 | -5.45 | -6.70 | -1.40 | -9.10 | -8.80 | -5.90 | -5.90 | -9.50 | 5.10 | -8.10 | -6.40 |
| Diluted Shares Outstanding | 13.08M | 8.58M | 8.49M | 8.46M | 8.31M | 8.25M | 8.2M | 8.12M | 6.15M | 6.1M | 6.06M | 6.03M |
| Basic Shares Outstanding | 13.08M | 8.58M | 8.49M | 8.46M | 8.31M | 8.25M | 8.2M | 8.12M | 6.15M | 6.1M | 6.06M | 6.03M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |